Tweet
I'm curious, has anyone tried the RNAse H method? An elegant method, but you'd have to construct a lot of oligos.
- Genohub
- Genohub
-
-
I've been playing around with the RNase H method, but it's proven a bit finicky for my samples, at least as far as the Bioanalyzer traces show. When it works, it really seems to work well, but I've also had a few test samples become completely degraded.
The method is patented, so I'm hoping that a commercial kit will be put out that supplies the oligos and full-proofs the method a bit more.
Very promising stuff though. -
Keep me updated if you ever attempt to sequence your RNase H samples. Did you design all the oligos yourself? I'm interested in designing some for mtRNA removal. Yes, a commercial kit would be nice. Anyone know of one coming?
- GenohubComment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment